Veralox Therapeutics
Frederick
About Veralox Therapeutics
Veralox Therapeutics develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type one diabetes. Based on an understanding of the molecular mechanisms of these diseases, these efforts will lead to new treatment paradigms and better outcomes for patients.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $47.5M
- Last round: Series Unknown (Jun 2023)
- Website: veralox.com
- Phone: (301) 360-3502
Industries & Categories
Biotechnology, Medical, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/veralox-therapeutics-32579 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.